Does Milk Thistle Liver Enzyme Randomized Trial work?

Updated May 2026

Quick Answer

Milk Thistle Liver Enzyme Randomized Trial has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) lacks treatment options, with few evidence-based choices beyond lifestyle modification.

Key Takeaways

  • 01Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) lacks treatment options, with few evidence-based choices beyond lifestyle modification. [Messier H (2026)]
  • 02Discussion This study provides preliminary evidence that this organic nutraceutical may improve steatosis grade in individuals with MASLD. [Messier H (2026)]
  • 03This is the first clinical study to assess the efficacy of an organic liquid oral nutraceutical composed of turmeric extract, dandelion powder, milk thistle extract, and ginger powder in MASLD. [Messier H (2026)]
  • 04Chronic liver disease is emerging as a public health priority in India, with the incidence of metabolic dysfunction-associated steatotic liver disease ranging between 8 and 20% depending on the region and contributing to 10 to 15% of deaths due to chronic liver disease (). [Patel Ghanashyam (2026)]
The current Migaku evidence database contains 2 reusable source documents for Milk Thistle Liver Enzyme Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - Introduction Metabolic dysfunction-associated steatotic liver disease (MASLD) lacks treatment options, with few evidence-based choices beyond lifestyle modification. [Messier H (2026); evidence level 2] - Discussion This study provides preliminary evidence that this organic nutraceutical may improve steatosis grade in individuals with MASLD. [Messier H (2026); evidence level 2] - This is the first clinical study to assess the efficacy of an organic liquid oral nutraceutical composed of turmeric extract, dandelion powder, milk thistle extract, and ginger powder in MASLD. [Messier H (2026); evidence level 2] - Chronic liver disease is emerging as a public health priority in India, with the incidence of metabolic dysfunction-associated steatotic liver disease ranging between 8 and 20% depending on the region and contributing to 10 to 15% of deaths due to chronic liver disease (). [Patel Ghanashyam (2026); evidence level 2] - Ginger () has been found to support healthy liver function, and to have antioxidant properties (). [Patel Ghanashyam (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Effectiveness and safety of an ayurvedic nutraceutical for improving clinical parameters of liver function in participants with metabolic dysfunction-associated steatotic liver disease: a randomized, placebo-controlled, preliminary phase 2 exploratory clinical trial.
  2. Long-term safety and efficacy of a highly purified plant-based nutraceutical for improving clinical parameters of liver function in healthy participants: a randomized, double-blind, placebo-controlled clinical trial